RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $65
Hinge Health, Inc. Class A
Hinge Health, Inc. Class A HNGE | 0.00 |
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:
HNGE) with a Outperform and raises the price target from $55 to $65.